/

Empresas

De

No verificado

Dermavant Sciences

Sobre qué escribimos

CienciaFarmacéuticaIndustriaMedicina - VariosSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa

25/10/2024

Industria

Ciencia

Biotecnología

Farmacéutica

Sanidad

Salud

Higiene alimentaria

Medicina - Varios

Dermavant Presents ADORING 3 LTE Final Data on Complete Skin Clearance and Treatment-Free Interval for VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as Two Years Old with Atopic Dermatitis at 2024 Fall Clinical Dermatology Conference

Fuente

Dermavant Sciences

Editor

1.00

0

24/10/2024

Eventos

Industria

Biotecnología

Farmacéutica

Salud

Dermavant Presents Data on Achievement of No-to-Minimal Itch and Sleep Improvement in Atopic Dermatitis Patients as Young as Two Years Old at American College of Allergy, Asthma and Immunology Annual Meeting

Fuente

Dermavant Sciences

Editor

1.00

0

25/06/2024

Industria

Ciencia

Higiene alimentaria

Biotecnología

Sanidad

Farmacéutica

Salud

Venta al público/Minorista

Dermavant Announces Approval of Tapinarof in both Psoriasis and Atopic Dermatitis in Japan

Fuente

Dermavant Sciences

Editor

1.00

0

Seguidores

0

Compatibilidad

0